UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Glytabastan B, a coumestan isolated from Glycine tabacina, alleviated synovial inflammation, osteoclastogenesis and collagen-induced arthritis through inhibiting MAPK and PI3K/AKT pathways Journal article
Tu, Yanbei, Tan, Lihua, Lu, Tao, Wang, Kai, Wang, Haiyong, Han, Bing, Zhao, Yuxin, Chen, Hanbin, Li, Yanfang, Chen, Haixia, Chen, Meiwan, He, Chengwei. Glytabastan B, a coumestan isolated from Glycine tabacina, alleviated synovial inflammation, osteoclastogenesis and collagen-induced arthritis through inhibiting MAPK and PI3K/AKT pathways[J]. Biochemical Pharmacology, 2022, 197, 114912.
Authors:  Tu, Yanbei;  Tan, Lihua;  Lu, Tao;  Wang, Kai;  Wang, Haiyong; et al.
Favorite | TC[WOS]:12 TC[Scopus]:15  IF:5.3/5.2 | Submit date:2022/03/28
Glycine Tabacina  Glytabastan b  Inflammation  Network Pharmacology  Osteoclast  Rheumatoid Arthritis  
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:  Yuxin Zhao;  Haiyong Wang;  Chengwei He
Favorite | TC[WOS]:20 TC[Scopus]:19  IF:2.7/3.1 | Submit date:2021/12/08
Non-small Cell Lung Cancer  Targeted Therapy  Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor  Drug Resistance